Non-Invasive Blood Glucose Monitoring device Clinical Trial Analysis

Summary

Global Markets Direct's "Non-Invasive Blood Glucose Monitoring device Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Non-Invasive Blood Glucose Monitoring device manufacturers, globally. The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.

Scope

• The report provides analysis and review of the key clinical trials being carried out globally and across key Non-Invasive Blood Glucose Monitoring device market categories - Non-Invasive Blood Glucose Monitoring device
• The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc.
• The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results
• The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy

• Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.
• Stay ahead of the information curve in the fast changing Non-Invasive Blood Glucose Monitoring device market.
• Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.
• Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Contents

• 1 List of Tables
• 1.2 List of Figures
• 2 Non-Invasive Blood Glucose Monitoring device Clinical Trials
  • 2.1 Non-Invasive Blood Glucose Monitoring device Clinical Trial By Equipment Type
  • 2.2 Non-Invasive Blood Glucose Monitoring device Clinical Trials By Trial Phase and Trial Status
  • 2.3 Non-Invasive Blood Glucose Monitoring device Pipeline Products By Development Stage
  • 2.4 Non-Invasive Blood Glucose Monitoring device Pipeline Products By Therapy Area
  • 2.5 Non-Invasive Blood Glucose Monitoring device Pipeline Products By News Summary
  • 2.6 Non-Invasive Blood Glucose Monitoring device SENTRIS-100
    • 2.6.1 First Hypoglycemic Clamping Study of Sentris-100 Completed
  • 2.7 Non-Invasive Blood Glucose Monitoring device Non-invasive continuous glucose monitor
    • 2.7.1 Repetition Trial at the University Hospital Zrich
    • 2.7.2 Solianis' Multisensor System In Home-Use Trial
  • 2.8 Non-Invasive Blood Glucose Monitoring device Sensys GTS
    • 2.8.1 Evaluation of a non-invasive glucose monitor through an independent multi-center clinical study
  • 2.9 Non-Invasive Blood Glucose Monitoring device NBM-200G
    • 2.9.1 The accuracy, safety and efficacy of the NBM-200G were demonstrated in a clinical trial which assessed a full range of blood glucose levels and a variety of glucose monitoring applications
    • 2.9.2 Performance Of A Non-Invasive Continuous Glucose Monitor In A Multi-Center Clinical Trial
  • 2.10 Non-Invasive Blood Glucose Monitoring device HypoMon
    • 2.10.1 Hypoglycaemia Detection Study
    • 2.10.2 Hypoglycaemia Detection Study - Princess Margaret Hospital
  • 2.11 Non-Invasive Blood Glucose Monitoring device Glucose Monitoring Device
    • 2.11.1 Non-Invasive Blood Glucose Measurement Using Multiple Laser Diodes
• 3 Recent Developments
  • 3.1 Product News
    • 3.1.1 Nov 13, 2008: Echo Therapeutics To Present Clinical Study Results Of Its Symphony Transdermal Continuous Glucose Monitoring System
    • 3.1.2 Aug 01, 2008: Echo Reports Positive Data For Non-Invasive Glucometer
    • 3.1.3 Jul 29, 2008: Echo Therapeutics Announces Positive Results Of A Clinical Study Of Its Symphony Transdermal Continuous Glucose Monitoring System
    • 3.1.4 Jul 14, 2008: Echo Therapeutics Announces Publication Of Positive Clinical Data For Its Symphony Transdermal Continuous Glucose Monitoring System
    • 3.1.5 Jan 02, 2008: Echo Therapeutics Starts Clinical Study Of Its Symphony Continuous Transdermal Glucose Monitoring System
  • 3.2 Clinical Trials
    • 3.2.1 Nov 13, 2008: Echo Therapeutics To Present Clinical Study Results Of Its Symphony Transdermal Continuous Glucose Monitoring System
    • 3.2.2 Aug 01, 2008: Echo Reports Positive Data For Non-Invasive Glucometer
    • 3.2.3 Jul 29, 2008: Echo Therapeutics Announces Positive Results Of A Clinical Study Of Its Symphony Transdermal Continuous Glucose Monitoring System
    • 3.2.4 Jul 14, 2008: Echo Therapeutics Announces Publication Of Positive Clinical Data For Its Symphony Transdermal Continuous Glucose Monitoring System
• 4 Appendix
  • 4.1 Methodology
    • 4.1.1 Coverage
    • 4.1.2 Secondary Research
    • 4.1.3 Primary Research
    • 4.1.4 Expert Panel Validation
  • 4.2 Contact Us
  • 4.3 About Global Markets Direct
  • 4.4 Disclaimer
• 1 List of Tables
  • Table 1: Non-Invasive Blood Glucose Monitoring device Clinical Trial By Equipment Type
  • Table 2: Non-Invasive Blood Glucose Monitoring device Clinical Trials By Trial Phase and Trial Status
  • Table 3: Non-Invasive Blood Glucose Monitoring device Pipeline Products By Development Stage
  • Table 4: Non-Invasive Blood Glucose Monitoring device Pipeline Products By Therapy Area
  • Table 5: Non-Invasive Blood Glucose Monitoring device Pipeline Products By News Summary
  • Table 6: SENTRIS-100 - First Hypoglycemic Clamping Study of Sentris-100 Completed
  • Table 7: Non-invasive continuous glucose monitor - Repetition Trial at the University Hospital Zrich
  • Table 8: Non-invasive continuous glucose monitor - Solianis' Multisensor System In Home-Use Trial
  • Table 9: Sensys GTS - Evaluation of a non-invasive glucose monitor through an independent multi-center clinical study
  • Table 10: NBM-200G - The accuracy, safety and efficacy of the NBM-200G were demonstrated in a clinical trial which assessed a full range of blood glucose levels and a variety of glucose monitoring applications
  • Table 11: NBM-200G - Performance Of A Non-Invasive Continuous Glucose Monitor In A Multi-Center Clinical Trial
  • Table 12: HypoMon - Hypoglycaemia Detection Study
  • Table 13: HypoMon - Hypoglycaemia Detection Study - Princess Margaret Hospital
  • Table 14: Glucose Monitoring Device - Non-Invasive Blood Glucose Measurement Using Multiple Laser Diodes
• 1.2 List of Figures
  • Figure 1: Global Markets Direct Methodology